Insider · CIK 0001734389

Chin Mark

Reports to the SEC for 5 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001734389

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,212 sh	—	—	6,212
2025-06-11	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-06-12	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,300 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−13.2K sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,033 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,016 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,214 sh	—	—	0
2024-03-08	Harpoon Therapeutics, Inc.A Award	Director	AAward	+424 sh	—	—	13,224
2024-01-01	Harpoon Therapeutics, Inc.A Award	Director	AAward	+1,072 sh	—	—	12,801
2023-11-27	Harpoon Therapeutics, Inc.A Award	Director	AAward	+5,000 sh	—	—	11,729
2023-10-01	Harpoon Therapeutics, Inc.A Award	Director	AAward	+3,035 sh	—	—	6,729
2023-07-01	Harpoon Therapeutics, Inc.A Award	Director	AAward	+18.7K sh	—	—	36,941
2023-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,000
2023-06-15	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.9K sh	—	—	0
2023-06-15	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+15.9K sh	—	—	18,306
2023-06-09	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,136 sh	—	—	7,136
2023-04-01	Harpoon Therapeutics, Inc.A Award	Director	AAward	+18.3K sh	—	—	18,285
2022-12-29	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2022-06-23	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+36.8K sh	—	—	36,798
2022-06-23	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−36.8K sh	—	—	0
2022-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+32.1K sh	$1.40	+$45K	32,142
2022-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2022-06-15	ITRMIterum Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+238K sh	$0.01	+$2,377.95	237,795
2022-06-02	ELVNEnliven Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2022-04-21	PYXSPyxis Oncology, Inc.S Sale	Former Director	SSale	−1.75M sh	$3.05	−$5.32M	0
2022-03-31	PYXSPyxis Oncology, Inc.A Award	Former Director	AAward	+66.8K sh	—	—	66,831
2021-10-13	PYXSPyxis Oncology, Inc.P Purchase	Former Director	PPurchase	+313K sh	$16.00	+$5M	1,745,761
2021-10-13	PYXSPyxis Oncology, Inc.C Conversion	Former Director	CConversion	+1.43M sh	—	—	1,433,261
2021-10-13	PYXSPyxis Oncology, Inc. · Series B Convertible Preferred StockC Conversion	Former Director	CConversion	−9.11M sh	—	—	0
2021-10-07	PYXSPyxis Oncology, Inc. · Stock Option (Right to buy)A Award	Former Director	AAward	+42.2K sh	—	—	42,191
2021-07-16	ELVNEnliven Therapeutics, Inc.P Purchase	Director	PPurchase	+1.33M sh	$6.00	+$8M	2,344,072
2021-06-29	ELVNEnliven Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+7,728 sh	—	—	7,728
2021-06-23	ITRMIterum Therapeutics plc · Restricted Stock UnitsA Award	Director	AAward	+36.8K sh	—	—	36,798
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+2,438 sh	—	—	2,438
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+3,017 sh	—	—	3,017
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2020-07-28	ITRMIterum Therapeutics plcJ Other	Director	JOther	−11.9K sh	—	—	0
2020-07-01	ITRMIterum Therapeutics plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,703 sh	—	—	0
2020-07-01	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+5,703 sh	—	—	11,857
2020-05-28	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+3,017 sh	—	—	3,017
2020-05-28	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2020-04-07	ITRMIterum Therapeutics plcJ Other	Director	JOther	−1.09M sh	—	—	0
2020-04-07	ITRMIterum Therapeutics plc · 6.500% Exchangeable Senior Subordinated Note due 2025J Other	Director	JOther	—	—	—	0
2020-03-16	ELVNEnliven Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−8.61M sh	—	—	0
2020-03-16	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,457
2020-03-16	ELVNEnliven Therapeutics, Inc.C Conversion	Director	CConversion	+1.37M sh	—	—	1,367,058
2020-03-16	ELVNEnliven Therapeutics, Inc.P Purchase	Director	PPurchase	+188K sh	$16.00	+$3M	1,554,558
2020-01-21	ITRMIterum Therapeutics plc · 6.500% Exchangeable Senior Subordinated Note due 2025A Award	Director	AAward	—	$1900000.00	—	—

Recent filings

Accepted (ET)
Jun 234
Chin Mark0001193125-26-279708
SEC(opens sec.gov)
Jun 134
Chin Mark0000950170-25-086374
SEC(opens sec.gov)
Jun 144
Chin Mark0000950170-24-073671
SEC(opens sec.gov)
Mar 114
Chin Mark0000950170-24-029439
SEC(opens sec.gov)
Jan 34
Chin Mark0000950170-24-000959
SEC(opens sec.gov)
Nov 284
Chin Mark0001209191-23-056794
SEC(opens sec.gov)
Oct 24
Chin Mark0001209191-23-051148
SEC(opens sec.gov)
Jul 64
Chin Mark0001209191-23-041673
SEC(opens sec.gov)
Jun 234
Chin Mark0001209191-23-039404
SEC(opens sec.gov)
Jun 154
Chin Mark0001209191-23-037405
SEC(opens sec.gov)
Jun 94
Chin Mark0000899243-23-015275
SEC(opens sec.gov)
Apr 44
Chin Mark0001209191-23-022794
SEC(opens sec.gov)
Jan 34
Chin Mark0000899243-23-000309
SEC(opens sec.gov)
Jun 244
Chin Mark0001209191-22-039313
SEC(opens sec.gov)

Companies

Address

C/O DISC MEDICINE, INC. 321 ARSENAL STREET, SUITE 101

WATERTOWN, MA, 02472